|
|
Article: IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules.
- Article from:
- Business Wire
- Article date:
- January 23, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
-Marketing to Begin Immediately-
HAYWARD, Calif. -- IMPAX Laboratories, Inc. (OTC: IPXL), through its generic drug division Global Pharmaceuticals, announced that yesterday the U.S. Food and Drug Administration (FDA) granted final approval of the Company's Abbreviated New Drug Application (ANDA) for a generic version of Prilosec 40 mg Delayed-release Capsules. AstraZeneca markets Prilosec for the treatment of duodenal/gastric ulcers and GERD (gastro-esophageal reflux disease).
The Company's versions of generic Prilosec (including previously approved and marketed 10 mg and 20 mg Capsules) are one of 12 products covered under its strategic alliance entered ...
Related newspaper, magazine, and journal articles:
|
|
Article: Impax Laboratories, Inc. (OTCBB: IPXL) just ...
M2 Presswire;
March 3, 2009 ;
700+ words
... ... March 2009-Stockwire.com: Impax Laboratories, Inc. (OTCBB: IPXL) just ... COMMUNICATIONS LTD RDATE:03032009 Impax Laboratories, Inc. (OTCBB: IPXL ... HAYWARD, Calif. -- Impax Laboratories, Inc. (OTCBB: IPXL) today ...
|
|